logo

Regeneron Pharmaceuticals (REGN)



Trade REGN now with
  Date
  Headline
6/24/2020 3:29:21 PM Regeneron To Defend Allegations Related To Contributions To Patient Assistance Charity In 2013 And Early 2014
6/24/2020 2:02:44 PM REGN:Data Shows Potential To Enhance Cancer Treatment By Combining Novel CostimulatoryBispecific Antibodies With Libtayo
6/19/2020 7:33:39 AM Regeneron And Sanofi: NMPA In China Approves Dupixent For Moderate-to-severe Atopic Dermatitis In Adults
6/11/2020 7:21:13 AM Regeneron Says Two Science Publications Highlight Potential Of REGN-COV2 Anti-Viral Antibody Cocktail
6/11/2020 7:02:23 AM Regeneron Begins First Clinical Trial Of REGN-COV2, Its Investigational Dual Antibody Cocktail For COVID-19
6/11/2020 1:01:42 AM Regeneron Announces Updates Related To Dupixent Collaboration Programs With Sanofi
6/1/2020 7:02:19 AM Regeneron And Intellia To Co-develop Potential Hemophilia A And B Treatments
5/29/2020 8:03:53 AM Regeneron Pharma And Sanofi Announce Longer-term Data From Pivotal Phase 2 Trial For PD-1 Inhibitor Libtayo